1,1-dichloroethene increases expression ISO RGD:1551409 6480464 vinylidene chloride results in increased expression of BACE2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1551409 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BACE2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1551409 6480464 1, 2-Dimethylhydrazine results in decreased expression of BACE2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of BACE2 mRNA CTD PMID:17557909 17beta-estradiol increases expression ISO RGD:1350115 6480464 Estradiol results in increased expression of BACE2 mRNA CTD PMID:21185374 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1551409 6480464 Tetrachlorodibenzodioxin results in increased expression of BACE2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BACE2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BACE2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1350115 6480464 Tetrachlorodibenzodioxin results in decreased expression of BACE2 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551409 6480464 Tetrachlorodibenzodioxin affects the expression of BACE2 mRNA CTD PMID:21570461 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of BACE2 mRNA CTD PMID:28300664 4,4'-sulfonyldiphenol increases expression ISO RGD:1551409 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of BACE2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases methylation ISO RGD:1350115 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of BACE2 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO RGD:1551409 6480464 Fenretinide results in increased expression of BACE2 mRNA CTD PMID:28973697 acrylamide increases expression ISO RGD:1350115 6480464 Acrylamide results in increased expression of BACE2 mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RGD:1350115 6480464 Aflatoxin B1 results in increased methylation of BACE2 intron CTD PMID:30157460 Aflatoxin B2 alpha affects methylation ISO RGD:1350115 6480464 aflatoxin B2 affects the methylation of BACE2 intron CTD PMID:30157460 antirheumatic drug increases expression ISO RGD:1350115 6480464 Antirheumatic Agents results in increased expression of BACE2 mRNA CTD PMID:24449571 aristolochic acid decreases expression ISO RGD:1350115 6480464 aristolochic acid I results in decreased expression of BACE2 mRNA CTD PMID:33212167 benzo[a]pyrene affects methylation ISO RGD:1350115 6480464 Benzo(a)pyrene affects the methylation of BACE2 intron CTD PMID:30157460 benzo[b]fluoranthene increases expression ISO RGD:1551409 6480464 benzo(b)fluoranthene results in increased expression of BACE2 mRNA CTD PMID:26377693 benzo[e]pyrene affects methylation ISO RGD:1350115 6480464 benzo(e)pyrene affects the methylation of BACE2 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 bisphenol A increases expression ISO RGD:1551409 6480464 bisphenol A results in increased expression of BACE2 mRNA CTD PMID:26063408 , PMID:34585602 bisphenol A multiple interactions ISO RGD:1350115 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of BACE2 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BACE2 mRNA CTD PMID:25181051 carbon nanotube decreases expression ISO RGD:1551409 6480464 Nanotubes, Carbon analog results in decreased expression of BACE2 mRNA CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:1350115 6480464 CGP 52608 promotes the reaction [RORA protein binds to BACE2 gene] CTD PMID:28238834 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of BACE2 mRNA CTD PMID:23125180 cisplatin increases expression ISO RGD:1350115 6480464 Cisplatin results in increased expression of BACE2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1350115 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of BACE2 mRNA CTD PMID:27392435 coumestrol multiple interactions ISO RGD:1350115 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1350115 6480464 Cyclosporine results in decreased expression of BACE2 mRNA CTD PMID:27989131 DDE multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 dibenz[a,h]anthracene increases expression ISO RGD:1551409 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 dioxygen increases expression ISO RGD:1350115 6480464 Oxygen deficiency results in increased expression of BACE2 mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:1350115 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1350115 6480464 Doxorubicin results in decreased expression of BACE2 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of BACE2 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1350115 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA CTD PMID:19167446 entinostat multiple interactions ISO RGD:1350115 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1350115 6480464 entinostat results in increased expression of BACE2 mRNA CTD PMID:26272509 , PMID:27188386 epoxiconazole multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 ethyl methanesulfonate increases expression ISO RGD:1350115 6480464 Ethyl Methanesulfonate results in increased expression of BACE2 mRNA CTD PMID:23649840 etoposide affects response to substance ISO RGD:1350115 6480464 BACE2 protein affects the susceptibility to Etoposide CTD PMID:16217747 folic acid decreases expression ISO RGD:1551409 6480464 Folic Acid results in decreased expression of BACE2 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1551409 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BACE2 mRNA CTD PMID:22206623 fonofos increases methylation ISO RGD:1350115 6480464 Fonofos results in increased methylation of BACE2 promoter CTD PMID:22847954 formaldehyde increases expression ISO RGD:1350115 6480464 Formaldehyde results in increased expression of BACE2 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:1350115 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of BACE2 gene CTD PMID:31601247 furan increases methylation EXP 6480464 furan results in increased methylation of BACE2 gene CTD PMID:22079235 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of BACE2 mRNA CTD PMID:22061828 , PMID:33387578 linuron multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of BACE2 protein CTD PMID:29341888 lovastatin multiple interactions ISO RGD:1350115 6480464 [Lovastatin co-treated with APP protein] results in increased expression of BACE2 protein CTD PMID:29341888 mercury dichloride affects expression ISO RGD:1350115 6480464 Mercuric Chloride affects the expression of BACE2 mRNA CTD PMID:24118919 methapyrilene affects methylation ISO RGD:1350115 6480464 Methapyrilene affects the methylation of BACE2 intron CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:1350115 6480464 Methyl Methanesulfonate results in increased expression of BACE2 mRNA CTD PMID:23649840 mitomycin C affects response to substance ISO RGD:1350115 6480464 BACE2 protein affects the susceptibility to Mitomycin CTD PMID:16217747 mitoxantrone affects response to substance ISO RGD:1350115 6480464 BACE2 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 panobinostat increases expression ISO RGD:1350115 6480464 panobinostat results in increased expression of BACE2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1350115 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:1350115 6480464 Acetaminophen results in decreased expression of BACE2 mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BACE2 mRNA CTD PMID:33387578 parathion increases methylation ISO RGD:1350115 6480464 Parathion results in increased methylation of BACE2 promoter CTD PMID:22847954 phenylmercury acetate increases expression ISO RGD:1350115 6480464 Phenylmercuric Acetate results in increased expression of BACE2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1350115 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA CTD PMID:27188386 potassium dichromate increases expression ISO RGD:1551409 6480464 Potassium Dichromate results in increased expression of BACE2 mRNA CTD PMID:23608068 prochloraz multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 procymidone multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 resveratrol increases expression ISO RGD:1551409 6480464 resveratrol results in increased expression of BACE2 mRNA CTD PMID:22610192 SB 431542 multiple interactions ISO RGD:1350115 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom decreases expression ISO RGD:1551409 6480464 Silver results in decreased expression of BACE2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1551409 6480464 Silver results in decreased expression of BACE2 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:1350115 6480464 sodium arsenite results in decreased expression of BACE2 mRNA CTD PMID:22714537 temozolomide decreases expression ISO RGD:1350115 6480464 Temozolomide results in decreased expression of BACE2 mRNA CTD PMID:31758290 terbufos increases methylation ISO RGD:1350115 6480464 terbufos results in increased methylation of BACE2 promoter CTD PMID:22847954 tert-butyl hydroperoxide decreases expression ISO RGD:1350115 6480464 tert-Butylhydroperoxide results in decreased expression of BACE2 mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:1551409 6480464 1 more ... CTD PMID:33848595 testosterone increases expression ISO RGD:1551409 6480464 Testosterone deficiency results in increased expression of BACE2 mRNA CTD PMID:33848595 tetrachloromethane decreases expression ISO RGD:1551409 6480464 Carbon Tetrachloride results in decreased expression of BACE2 mRNA CTD PMID:17484886 thimerosal decreases expression ISO RGD:1350115 6480464 Thimerosal results in decreased expression of BACE2 mRNA CTD PMID:27188386 trichostatin A increases expression ISO RGD:1350115 6480464 trichostatin A results in increased expression of BACE2 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:1350115 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1350115 6480464 Triclosan results in decreased expression of BACE2 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1551409 6480464 trimellitic anhydride results in decreased expression of BACE2 mRNA CTD PMID:19042947 troglitazone increases expression ISO RGD:1551409 6480464 troglitazone results in increased expression of BACE2 mRNA CTD PMID:28973697 valproic acid decreases methylation ISO RGD:1350115 6480464 Valproic Acid results in decreased methylation of BACE2 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1350115 6480464 Valproic Acid results in increased expression of BACE2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1350115 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:1350115 6480464 Valproic Acid affects the expression of BACE2 mRNA CTD PMID:25979313 vinclozolin multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892
